爱克莱恩

ACHN NASDAQ
2.790
-0.150
-5.10%
盘后: 2.790 0 0.00% 16:23 06/14 EDT
开盘
2.910
昨收
2.940
最高
2.940
最低
2.790
成交量
60.02万
成交均量(3M)
134.54万
52周最高
3.980
52周最低
1.290
换手率
0.43%
市值
3.87亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供爱克莱恩 ACHN股票价格,爱克莱恩股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small molecule compounds that have the potential to be used in the treatment of immune-related diseases associated with the alternative pathway of the complement system. The complement system is part of the human innate immune system. Its clinical compound from its complement inhibitor platform is ACH-4471. ACH-4471 is a potent and specific inhibitor of factor D, which demonstrated complete inhibition of the complement alternative pathway in human healthy volunteers in a Phase I clinical trial. The Company has discovered and advanced multiple compounds into clinical development, including sovaprevir, odalasvir, and ACH-3422 in its hepatitis C virus (HCV) program.
展开 >

最近浏览

名称
价格
涨跌幅